From: Volume change after maxillary sinus floor elevation with apatite carbonate and octacalcium phosphate
Cytrans® | Age | Sex | Deficit condition (FDI) | T2 (mL) | T3 (mL) | Absorbed amount (%) | |
---|---|---|---|---|---|---|---|
1 | 67 | F | 14–17 | 2.547 | 2.371 | 6.90 | |
2 | 41 | F | 16 | 2.108 | 1.791 | 15.00 | |
3 | 59 | M | 26,27 | 1.506 | 1.222 | 18.90 | |
4 | 67 | M | Edentulous | 3.763 | 3.375 | 10.30 | |
5 | 67 | M | Edentulous | 2.392 | 2.15 | 10.10 | |
6 | 67 | F | 24–27 | 2.78 | 2.386 | 14.20 | |
7 | 56 | F | 16,17 | 2.543 | 2.241 | 10.90 | |
8 | 62 | M | 15,16 | 2.863 | 2.568 | 10.30 | |
9 | 56 | M | 15,16 | 3.237 | 3.085 | 15.20 | |
10 | 70 | M | 15,16 | 1.42 | 1.261 | 15.90 |
Bonarc® | Age | Sex | Deficit condition (FDI) | Number of sheets | T2 (mL) | T3 (mL) | Absorbed amount (%) |
---|---|---|---|---|---|---|---|
1 | 40 | M | 26 | 16 | 1526.0 | 1323 | 13.30 |
2 | 69 | M | 16 | 10 | 953.8 | 724.3 | 24.10 |
3 | 80 | F | 13–16 | 13 | 1239.9 | 1068 | 13.90 |
4 | 21 | M | 14–16 | 17 | 1621.4 | 1250 | 22.90 |
5 | 61 | F | 26 | 20 | 1907.6 | 1596 | 16.30 |
6 | 67 | F | 25–27 | 18 | 1716.8 | 1474 | 14.10 |
7 | 73 | F | 24–27 | 20 | 1907.6 | 1613.2 | 15.40 |
8 | 40 | M | 24–27 | 15 | 1430.7 | 1139.3 | 20.40 |
9 | 59 | M | 24–27 | 20 | 1907.6 | 1628.4 | 14.60 |
10 | 68 | F | 14–17 | 20 | 1907.6 | 1563 | 18.10 |